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Background. The management of patients with colorectal liver metastases and loop ileostomies remains controversial. This study
was performed to assess the outcome of combined liver resection and loop ileostomy closure. Methods. Analysis of prospectively
collected perioperative data, including morbidity and mortality, of 283 consecutive hepatectomies for colorectal liver metastases
wasundertaken.Consecutiveliverresectionswereperformedfrom1996to2006inonecentrebyasinglesurgeon(NDK).Fourteen
of these patients had combined liver resection and ileostomy closure. Case-matched analysis was undertaken. Results.S i x( 2 . 2 % )
patients died in the hepatectomy only group and none died in the combined group. There was no diﬀerence in operative blood
loss between the two groups (0.09). Perioperative morbidity was 36% in the combined group and 23% in the hepatectomy alone
group (P = 0.33). Mean hospital stay was 14 days in the combined group and 11 days in the hepatectomy only group (P = 0.046).
Case-matched analysis showed a signiﬁcant increase in hospital stay (P = 0.03) and complications (P = 0.049) in the combined
group. Conclusion. In patients with CRLM, combined liver resection and closure of ileostomy may be associated with a higher
operative morbidity and a prolonged hospital stay.
Copyright © 2008 Jeﬀrey T. Lordan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Colorectal cancer is the second leading cause of cancer
death in the Western world [1, 2]. A quarter of the patients
with colorectal cancer have liver metastases at presentation
and 40% go on to develop liver metastases at a later stage
[3, 4]. Liver resection remains the only potentially curative
treatment for colorectal liver metastases (CRLM) [2–4].
Liver resections taking place in specialised high-volume
centresarewell-toleratedprocedureswithlowmorbidityand
mortality.
A number of patients with low-rectal cancers undergo
anterior resection with defunctioning loop ileostomy [5].
The closure of loop ileostomies is a reasonably straightfor-
ward procedure with low mortality and morbidity and short
hospital stay [5].
The aim of the study was to look at the impact of
concomitant loop ileostomy closures on the perioperative
morbidity and length of hospital stay after a liver resection.
2. MATERIALS AND METHODS
An analysis of 283 consecutive hepatic resections for CRLM,
undertaken between September 1996 and August 2006, was
performed. Data were collected and analysed prospectively
by a dedicated whole-time data clerk.
All patients had a staging laparoscopy and intraoperative
ultrasonography. Postoperative analgesia was achieved with
thoracic epidural.
Perioperative mortality was deﬁned as death during the
same hospital admission or within 30 days of the date of the
operation if the patient was discharged earlier. Postoperative
complications were classiﬁed as cardiac, respiratory, renal,
hepatic impairment, thromboembolic, sepsis, and wound
infections.
All loop ileostomies were closed using interrupted
sutures. In patients who underwent concomitant liver
resection and ileostomy closure, no other procedures were
performed.2 HPB Surgery
Table 1: Patients’ demographics and operative outcomes.
Hepatic resection alone (n = 269) Hepatic resection + loop stoma closure (n = 14) P-value
Male:female 2.2:1 1.8:1 N/A
Mean age/years (range) 66.5 (33 to 85.4) 62 (42 to 73) .13
ASA
N/A
(i) 1 51 (19%) 5 (36%)
(ii) 2 148 (55%) 6 (43%)
(iii) 3/4 36 (13%) 0
(iv) Not recorded 34 (13%) 3 (21%)
Type of liver resection
N/A (i) Hemihepatectomy 95 (35%) 6 (43%)
(ii) Extended hemihepatectomy 67 (25%) 4 (29%)
(iii) Parenchymal sparing resection 107 (40%) 4 (29%)
Number and distribution of liver metastases
N/A
(i) 1 125 8
(ii) 2 61 2
(iii) 3 33 3
(iv) 4 16 1
(v) >42 2 0
(vi) Bilateral liver mets 54 0
(vii) Complete response to chemotherapy 12 0
Repeat resections 12 0 <. 0001
Maximum tumours size/mm 31.5 (3 to 165) 28.5 (5 to 85) .16
Mean blood loss/mL (range) 262 (0 to 2500) 219.2 (0 to 2100) .09
Mean hospital stay/days (range) 11 (3 to 53) 14 (8 to 23) .046
ASA = American Society of Anesthesiologists.
Table 2: Perioperative complications.
Complication Hepatic resection alone (n = 269) Hepatic resection + loop stoma closure (n = 14)
Cardiac 14 0
Respiratory chest infection 7 1
Respiratory failure 7 0
Renal 3 0
Liver insuﬃciency 5 0
Thromboembolic 1 0
Sepsis 5 0
Intestinal obstruction 0 1
Deep wound infection 9 2
Bile leak 11 1
Total (%) 62 (23%) 5 (36%)
P = .33.
Due to the discrepancy in the number of patients
between the two groups, a case-matched analysis was carried
out. This directly compared the patients who underwent
concomitant loop ileostomy closure and liver resection
versus an equal number of patients who underwent liver
resection alone. The patients who underwent liver resection
alone were matched for type of liver resection, age, and
American Society of Anesthesiologists (ASA). They also had
loop ileostomies that had been formed at their primary
colorectal resection which were reversed at a separate time
to the liver resection.
Chi-squared and t-tests were used to analyse data. P-
value less than .05 was considered to be signiﬁcant.
3. RESULTS
Of the 283 patients undergoing liver resection for CRLM,
14 had a combined liver resection and concomitant loop
ileostomy closure. The median time from the formation of
loop ileostomy to closure was 252 days (range 68 to 662
days).Jeﬀrey T. Lordan et al. 3
Table 3: Case-matched analysis.
Hepatic resection alone (n = 14) Hepatic resection + loop stoma closure (n = 14) P-value
Male:female 2.6:1 1.8:1 N/A
Mean age/years (range) 59.7 (34 to 77) 62 (42 to 73) .6
ASA
N/A
(i) 1 5 (36%) 5 (36%)
(ii) 2 6 (43%) 6 (43%)
(iii) 3/4 2 (14%) 0
(iv) Not recorded 1 (7%) 3 (21%)
Type of liver resection
N/A (i) Hemihepatectomy 6 (43%) 6 (43%)
(ii) Extended hemihepatectomy 3 (21%) 4 (29%)
(iii) Parenchyma sparing resection 5 (36%) 4 (29%)
Number and distribution of liver metastases
N/A
(i) 1 8 8
(ii) 2 4 2
(iii) 3 1 3
(iv) 4 0 1
(v) >41 0
(vi) Bilateral liver mets 3 0
Maximum tumours size/mm 26.5 (4 to 130) 28.5 (5 to 85) .5
Mean blood loss/mL (range) 216 (30 to 2500) 219 (<20 to 2100) .15
Mean hospital stay/days (range) 11 (6 to 15) 14 (8 to 23) .03
Complications 1 (7.1%) 5 (36%) .049
Serious complications (grade III or above) [6] 0 2 (14%) .13
Table 1 demonstrates patients’ demographics and peri-
operative outcomes. There was no signiﬁcant diﬀerence in
age or median blood loss between the two groups (P = .13
and .09, resp.). Hospital stay was longer in the group who
had a concomitant liver resection and loop ileostomy closure
(P = .04). There was no signiﬁcant diﬀerence in maximum
tumour size (P = .16). Hospital stay was signiﬁcantly longer
in the combined group (13 days versus 10 days, P = .046).
The number of repeat resections in the hepatectomy alone
group was signiﬁcantly higher (P<. 0001).
Table 2 shows the number and type of perioperative
complications. There were 62 (23%) complications in the
group who had a liver resection alone compared with 5
(36%) complications in the concomitant group (P = .33).
However, the number of serious complications (grade
III or above, according to the classiﬁcation of surgical
complications [6]) in the group who had a liver resection
alone was 18 (6.7%) versus 2 (14%) in the concomitant
group (P = .42).
There were 6 (2.2%) postoperative deaths in the hepa-
tectomy group. 3 died due to hepatic insuﬃciency, 2 due
to cardiac complications, and 1 due to sepsis. There were
no deaths in the group who had a liver resection and loop
ileostomy closure.
Table 3 demonstrates a case-matched analysis of an equal
number of patients to the group who had concomitant loop
ileostomyclosureandliverresection.Therewasnodiﬀerence
in age, type of liver resection, ASA, number and distribution
of liver metastases, maximum tumour size, or blood loss.
Hospital stay was signiﬁcantly longer in the concomitant
group (P = .03) as was the complication rate (P = .049),
although serious complication rates were not signiﬁcantly
diﬀerent (0.13). There were no postoperative deaths in these
two groups.
4. DISCUSSION
Loop, or defunctioning, ileostomies are often created to
minimise the impact of peritoneal sepsis from an anas-
tomotic dehiscence following coloanal or low-colorectal
anastomosis [5, 7]. However, it probably does not reduce
the incidence of anastomotic leak [5, 8–10]. The patients
in this series appear to have had a substantial delay in time
from formation to closure compared to the literature [5, 7].
Loop ileostomy closure is often considered low priority by
clinicians [5, 7], and it is likely that more consideration
was given to treating the liver metastases, with neoadjuvant
chemotherapy followed by liver resection.
Patients suitable for hepatectomy often request a closure
of their loop ileostomy at the time of liver resection.
However, to the authors’ knowledge, there is no documented
evidence demonstrating the safety of this combined proce-
dure compared with hepatectomy alone.
Anecdotally, it was felt in our institution that loop
ileostomy closure combined with liver resection increased
morbidity. The analysis of the data shows that there was
a substantial increase in complications with the combined
procedure, although it did not reach signiﬁcance, possibly4 HPB Surgery
due to the low numbers involved. Although there were no
postoperative deaths in the group who had the combined
procedure, there is an evidence that increased frequency
of complications during the perioperative period can be
associated with a signiﬁcantly higher mortality regarding
hepatectomy [11]. The analysis of the case-matched series,
however, did show a signiﬁcant increase in complications in
the concomitant group, although there was no diﬀerence in
serious complications [6]. Further evidence of the impact
of combining these two procedures was demonstrated by
the signiﬁcant increase in hospital stay both in the overall
analysis and the case-matched analysis.
The literature reports perioperative morbidity regarding
liver resection for CRLM at 13–37% [1, 12, 13]. However,
complicationratesassociatedwithhepatectomyhavesteadily
improved over the years partly due to accurate patient
assessment and selection and improved critical care. The
mortality in the hepatectomy alone group was 2.2%. In the
literature, operative mortality for liver resection has reduced
over the years to less than 5% in experienced centres due to
improved patient assessment and selection [14, 15]. Three of
thesixpatientsinourseriesdiedduetohepaticinsuﬃciency.
This may be related to intraoperative Pringle manoeuvres,
or the use of neoadjuvant chemotherapy, which can be
associated with nonalcoholic steatohepatitis (NASH) [16].
Recently, articles have reported that loop stoma closure
as a procedure in its own right can be associated with a
substantial morbidity, and is not necessarily the “easy, low-
risk” procedure it may once have been considered [17, 18].
This may explain the substantial increase in morbidity in
patients undergoing closure of loop ileostomy combined
with hepatectomy found in this study. The increased compli-
cation rate may also explain the signiﬁcantly higher hospital
stay seen in the group who had the combined procedure.
Although there were diﬀerences in outcomes between
the two groups, the study is limited not only due to
the numbers but also due to the potential diﬀerence in
disease biology between them. However, a recent study
comparing hepatectomy and synchronous colonic resection
versus colonic resection alone concluded that combining
the procedure signiﬁcantly increases the hospital stay and
morbidity rate, reporting a median hospital stay of 13.9 days
and complication rate of 56.3% [19].
Patients occasionally request that their loop stoma be
closed at the time of hepatectomy. In such cases, the risks
demonstrated in this article can be presented to patients
before making an informed decision.
In conclusion, combined liver resection and concomitant
closure of loop ileostomy may be associated with increased
perioperative morbidity and prolonged hospital stay.
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